España
India
Italia
대한민êµ
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise
Contribute
España
India
Italia
대한민êµ
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Screeners
Stock Screener
Top Momentum Stocks
Top Quality Stocks
Top Value Stocks
Top Growth Stocks
Recent
Markets
CRT Capital
CRT Downgrades BorgWarner To Neutral
Yahoo Remains 'Focus Pick' For CRT Capital Despite Aabaco Tax Drama
CRT Capital Upgrades United Continental To Buy, Sees Merger Integration In 'Seventh Inning'
Yahoo Remains 'Focus Pick' For CRT Capital Despite Aabaco Tax Drama
CRT Capital Upgrades United Continental To Buy, Sees Merger Integration In 'Seventh Inning'
CRT Capital Upgrades United Continental To Buy
CRT Capital Initiates Coverage On Ultragenyx Pharmaceutical
CRT Capital Upgrades United Continental To Buy
|
CRT Capital Initiates Coverage On Ultragenyx Pharmaceutical
|
CRT Raises JetBlue Price Target, Says 2015 Could Be Year Investors Have Been Waiting For
|
Here's Why CRT Capital Upgraded Pandora
|
Read More...
CRT Capital Recent News
CRT Capital Upgrades Pandora Media To Buy
|
US Stock Futures Down; All Eyes On Fed Decision
|
CRT Capital Initiates B/E Aerospace With Buy
|
Why Valeant, Not Endo, Could Still Win The War For Salix
|
CRT Capital Upgrades Skullcandy To Buy
|
UPDATE: CRT Capital Upgrades Sturm, Ruger & Company As Industry Outlook Continues To Improve
|
CRT Capital Initiates Ligand Pharmaceuticals With Buy
|
Zillow: 2 Analysts Weigh In With 2 Widely Different Views
|
The Street Likes Virgin America After Solid Earnings Report
|
CRT Capital Raises JetBlue Airways Price Target
|
Analysts React Positively To Facebook Earnings
|
CRT Capital: Risk To Amazon EPS On Downside
|
Barclays Issues 3 Upgrades, 1 Downgrade On Pharma Stocks
|
CRT Raises Price Target On Valeant Pharmaceuticals, 'Well Positioned For Growth'
|
CRT Capital Comments On GT Advanced Technologies Bankruptcy Proceedings; Recent Developments 'Generally Negative' For Bonds
|
CRT: Google To Benefit From Mobile Shift
|
JetBlue Reports November Traffic Increase Of 10.1%
|
CRT Capital: Google Getting Black Eye In Fight For Holiday Shoppers
|
Top 10 Biggest New Video Game IP Launches
|
UPDATE: CRT Capital Reiterates On Williams-Sonoma On Broad-Based Strength Heading Into Holiday
|
UPDATE: CRT Downgrades Verint Systems
|
CRT Reiterates On Twitter Following Analyst Day
|
PlayStation 4 Vs. Xbox One: Will Price Cuts Have An Impact This Holiday?
|